Laura Gatti graduated in October 1996 in Biochemistry and Physiology Department, Università degli Studi, Milan, Italy, where she also obtained her Ph.D. degree in applied biotechnology in Mar 2002, her National Board Certification (biologist) in October 1998, and her degree in biological sciences with full marks and honors in October 1996. She currently works as a Senior Research Scientist in the Molecular Pharmacology Unit, Istituto Nazionale Tumori, Milan, Italy, since December 2001. Gatti also served as a Visiting Research Scientist in the Functional Genomics Lab at The Wellcome Trust Sanger Institute, Cambridge, UK, from Septeb 2001 to November 2001, and a Research Fellow in the Department of Experimental Oncology, Istituto Nazionale Tumori, from November 1996 to August 2001. She received an EMBO short-term Fellowship to visit the Sanger Centre, Cambridge, UK (2001). Her expertise in cancer research has been established by contributing to projects related to molecular and biochemical pharmacology of antitumor agents. In 1996 she has joined the Istituto Nazionale Tumori in Milan, where she has been trained over the years to carry out preclinical and translational studies. Gatti has actively participated to fund raising activities from the beginning of her career. Her specific area of interest has been cellular resistance to cytotoxic/target-specific agents, with special focus on mechanisms of drug-resistance/drug-induced apoptosis and the strategies to overcome resistance. In 2001, she moved to the Sanger Institute in the lab directed by Dr. J. Bahler, for gene-expression profiles of fission yeast. Currently, Dr. Gatti holds a position of Senior Researcher in the Molecular Pharmacology Unit directed by Dr. N. Zaffaroni at the Istituto Nazionale Tumori in Milan. Recent scientific interests include the study of expression of ABC transporters in tumors, with particular emphasis on the discovery of new pharmacological modulators of multidrug-resistance phenotype.
Biography Updated on 3 February 2013